Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, National Health Investors, Inc. (NHI) has a Wall Street consensus price target of $85.20, based on estimates from 18 covering analysts. With the stock currently trading at $84.07, this represents a potential upside of +1.3%. The company has a market capitalization of $4.06B.
Analyst price targets range from a low of $83.00 to a high of $88.00, representing a 6% spread in expectations. The median target of $85.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, NHI trades at a trailing P/E of 27.8x and forward P/E of 25.5x. Analysts expect EPS to grow -99.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $9931.96, with bear and bull scenarios of $5070.21 and $11276.26 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how NHI stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for NHI is $85.2, close to the current price of $84.07 (1.3% implied move). Based on 18 analyst estimates, the stock appears fairly valued near current levels.
NHI has a consensus rating of "Hold" based on 18 Wall Street analysts. The rating breakdown is mixed, with 12 Hold ratings making up the largest segment. The consensus 12-month price target of $85.2 implies 1.3% upside from current levels.
NHI trades at a forward P/E of 25.5423x, representing a moderate valuation. With analysts targeting $85.2 (1.3% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $88 for NHI, while the most conservative target is $83. The consensus of $85.2 represents the median expectation. Our quantitative valuation model projects a bull case target of $11276 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NHI is well covered by analysts, with 18 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 12 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NHI stock forecast based on 18 Wall Street analysts shows a consensus price target of $85.2, with estimates ranging from $83 (bear case) to $88 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $9932, with bear/bull scenarios of $5070/$11276.
Our quantitative valuation model calculates NHI's fair value at $9932 (base case), with a bear case of $5070 and bull case of $11276. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
NHI trades at a forward P/E ratio of 25.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
NHI appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $85.2 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NHI analyst price targets range from $83 to $88, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $85.2 consensus represents the middle ground. Our model's $5070-$11276 range provides an independent fundamental perspective.